News in the Life Sciences Industry

STOCKHOLM, April 24, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the company will provide an update on patient recruitment in the ongoing phase 3 study OCEAN, as well as a general update from all the company's clinical studies in a webcast at 10.00am... Read more ››

STOCKHOLM, April 24, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical technology company focused on developing and commercializing innovative solutions for neurocritical care, announced today that it received a response from G-MED, its designated European... Read more ››

STOCKHOLM, April 24, 2019 /PRNewswire/ -- During the first quarter of 2019, we remained focused on our product launch strategy and continued to create value, as we reached several key objectives and took several steps towards the commercialization of IMMray(TM) PanCan-d, our diagnostic test for... Read more ››

GETINGE, Sweden, April 23, 2019 /PRNewswire/ -- At the Annual General Meeting of Getinge AB (publ) held on 23 April 2019, the following was resolved.

STOCKHOLM, April 23, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for intracranial bleeding pathologies, announced today it has published its 2018 annual report on... Read more ››

OSLO, Norway, April 23, 2019 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that the Company and its collaborators will present new interim clinical and biomarker... Read more ››

STOCKHOLM, April 23, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for intracranial bleeding pathologies, announced today it has entered into an agreement with the... Read more ››

GOTHENBURG, Sweden, April 23, 2019 /PRNewswire/ -- "We show strong organic growth and improved operating margin in the first quarter", says Mattias Perjos, President & CEO Getinge. "It is also positive to see that our gross margin is continuing to move in the right direction sequentially... Read more ››

STOCKHOLM, April 18, 2019 /PRNewswire/ -- Cantargia AB today announce that the phase I clinical data generated by the antibody CAN04 will be presented orally at the 2019 Annual ASCO meeting May 31 - June 3, 2019 in Chicago. The coordinating investigator Prof Ahmed Awada will present the data... Read more ››

STOCKHOLM, April 18, 2019 /PRNewswire/ - Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) has released the company's 2018... Read more ››